BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 22, 2002
View Archived Issues
Other News To Note
Read More
Teva’s Copaxone Failure In MS Attributed To Low Relapse Rate
Read More
Orchid Raises $23M Through Public Offering Of 8M Shares
Read More
Appointments And Advancements
Read More
Use Partners To Pack Pipeline But Not Too Early, Panel Says
NEW YORK - Partners matter. But products matter more, and the one can be used to reach the other, said Donald Drakeman, president and CEO of Medarex Inc., the transgenic mouse company with “about four dozen” collaborators. (BioWorld Today)
Read More
Cure, Not Just Therapy, Target For Cardio Drugs And Devices
Read More
Isis, Merck Form Collaboration Centered On Target Validation
Read More
Cypress Enters Deal To Raise $17M, If Shareholders Approve
Read More